Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1989 2
1991 2
1992 1
1994 1
1995 2
1996 1
1997 2
1998 4
1999 1
2000 6
2001 2
2002 8
2003 5
2004 5
2005 4
2006 6
2007 1
2008 1
2009 4
2010 6
2011 10
2012 9
2013 4
2014 1
2015 1
2016 5
2018 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer.
Gonzalvez F, Vincent S, Baker TE, Gould AE, Li S, Wardwell SD, Nadworny S, Ning Y, Zhang S, Huang WS, Hu Y, Li F, Greenfield MT, Zech SG, Das B, Narasimhan NI, Clackson T, Dalgarno D, Shakespeare WC, Fitzgerald M, Chouitar J, Griffin RJ, Liu S, Wong KK, Zhu X, Rivera VM. Gonzalvez F, et al. Among authors: clackson t. Cancer Discov. 2021 Jul;11(7):1672-1687. doi: 10.1158/2159-8290.CD-20-1683. Epub 2021 Feb 25. Cancer Discov. 2021. PMID: 33632773
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: clackson t. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.
Dimerizer-regulated gene expression.
Pollock R, Clackson T. Pollock R, et al. Among authors: clackson t. Curr Opin Biotechnol. 2002 Oct;13(5):459-67. doi: 10.1016/s0958-1669(02)00373-7. Curr Opin Biotechnol. 2002. PMID: 12459338 Review.
Redesigning small molecule-protein interfaces.
Clackson T. Clackson T. Curr Opin Struct Biol. 1998 Aug;8(4):451-8. doi: 10.1016/s0959-440x(98)80122-x. Curr Opin Struct Biol. 1998. PMID: 9729736 Review.
RASSLing with receptors.
Clackson T. Clackson T. Nat Biotechnol. 1999 Feb;17(2):131-2. doi: 10.1038/6128. Nat Biotechnol. 1999. PMID: 10052342 No abstract available.
Regulated gene expression systems.
Clackson T. Clackson T. Gene Ther. 2000 Jan;7(2):120-5. doi: 10.1038/sj.gt.3301120. Gene Ther. 2000. PMID: 10673717 Review.
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.
Jenkins KA, Park M, Pederzoli-Ribeil M, Eskiocak U, Johnson P, Guzman W, McLaughlin M, Moore-Lai D, O'Toole C, Liu Z, Nicholson B, Flesch V, Qiu H, Clackson T, O'Hagan RC, Rodeck U, Karow M, O'Neil J, Williams JC. Jenkins KA, et al. Among authors: clackson t. J Immunother Cancer. 2023 Dec 12;11(12):e007785. doi: 10.1136/jitc-2023-007785. J Immunother Cancer. 2023. PMID: 38164757 Free PMC article.
Dimerizer-mediated regulation of gene expression.
Rivera VM, Berk L, Clackson T. Rivera VM, et al. Among authors: clackson t. Cold Spring Harb Protoc. 2012 Jul 1;2012(7):767-70. doi: 10.1101/pdb.top070128. Cold Spring Harb Protoc. 2012. PMID: 22753597
89 results